AE Succinimide, an Analogue of Methyllycaconitine, When Bound Generates a Nonconducting Conformation of the α4β2 Nicotinic Acetylcholine Receptor

• Published in: ACS chemical neuroscience 2020-02, Vol.11 (3), p.344-355
• Main Authors: Qudah, Taima, Quek, Gracia X, Indurthi, Dinesh, Karim, Nasiara, Halliday, Jill I, Absalom, Nathan, McLeod, Malcolm D, Chebib, Mary
• Format: Article
• Language: English
• Subjects: Acetylcholine - metabolism; Aconitine - analogs & derivatives; Aconitine - pharmacology; alpha7 Nicotinic Acetylcholine Receptor - drug effects; alpha7 Nicotinic Acetylcholine Receptor - metabolism; Animals; Binding Sites - drug effects; Membrane Potentials - drug effects; Nicotinic Antagonists - pharmacology; Oocytes - drug effects; Oocytes - metabolism; Protein Subunits - metabolism; Receptors, Nicotinic - drug effects; Receptors, Nicotinic - metabolism; Succinimides - chemistry; Succinimides - pharmacology; Xenopus laevis - metabolism
• ISSN: 1948-7193; 1948-7193
• DOI: 10.1021/acschemneuro.9b00525

Nicotinic acetylcholine (nACh) receptors are pentameric ligand-gated ion channels that mediate fast synaptic transmission. The α4β2 nACh receptor is highly expressed in the brain and exists in two functional stoichiometries: the (α4)2(β2)3 and (α4)3(β2)2 that differ by an ACh-binding site at the α4−α4 interface of (α4)3(β2)2 receptors. Methyllycaconitine (MLA) is an nACh receptor antagonist, and while potent at both α7 and α4β2 nACh receptors, it has a higher selectivity for the α7 nACh receptor. The anthranilate-succinimide ester side-chain is important for its activity and selectivity. Here we identify a simplified MLA analogue that contains only the A and E ring skeleton of MLA, AE succinimide, that binds close to the channel lumen to display insurmountable inhibition at α4β2 nACh receptors. Although inhibition by AE succinimide was found to be voltage-dependent indicating a possible pore channel blocker, substituted-cysteine accessibility experiments indicated it did not bind between 2′–16′ region of the channel pore. Instead, we found that upon binding and in the presence of ACh, there is a conformational change to the channel membrane that was identified when the compound was assessed against (α4 V13′C)­β2 nACh receptors. It was found that in the 3:2 stoichiometry the two adjacent α4 subunits containing 13′ cysteine mutations formed a disulfide bond and occluded ion conductance. This was reversed by treatment with the reducing agent, dithiothreitol. Thus, AE succinimide has a different mechanism of inhibition to both MLA and other AE analogues, such as AE bicyclic alcohol, in that upon binding to an as yet unidentified site, AE succinimide in the presence of ACh induces a conformational change to the channel that generates a ligand-bound closed state.